Intravenous thrombolysis before endovascular therapy for large vessel strokes can lead to significantly higher hospital costs without improving outcomes
Background Limited efficacy of IV recombinant tissue plasminogen activator (rt-PA) for large
vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy …
vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy …
A population-based incidence of M2 strokes indicates potential expansion of large vessel occlusions amenable to endovascular therapy
AT Rai, JR Domico, C Buseman… - Journal of …, 2018 - jnis.bmj.com
Background M2 occlusions may result in poor outcomes and potentially benefit from
endovascular therapy. Data on the rate of M2 strokes is lacking. Methodology Patients with …
endovascular therapy. Data on the rate of M2 strokes is lacking. Methodology Patients with …